Scholarlink

Purpose <p>This study aimed to improve the serological identification of urogenital mycoplasmas through the development of MUREAPLEXE, a recombinant protein-based multiplex ELISA allowing the simultaneous and specific detection of antibodies against <i>Metamycoplasma hominis</i>,<i> Ureaplasma parvum</i> and <i>Ureaplasma urealyticum</i>.</p> Methods <p>Genes encoding the major surface antigens Vaa and P120’ of <i>M. hominis</i>, MBA3 of <i>U. parvum</i> and MBA8 of <i>U. urealyticum</i> were cloned into the prokaryotic expression vector pGEX-4T-1 and expressed in <i>E. coli</i> BL21. Recombinant GST-fusion proteins were purified by affinity chromatography using Glutathione-Sepharose 4B beads and were used to optimize an indirect multiplex ELISA. Both assays were subsequently evaluated using 162 patient sera that had been previously characterized by indirect immunofluorescence (IIF) and Western blot analysis.</p> Results <p>Relative to IIF, both ELISA assays demonstrated high sensitivity. All tested sera showed reactivity with their corresponding recombinant antigens. Statistical analyses demonstrated a significant correlation between the two ELISA tests. However, MUREAPLEXE demonstrated markedly higher specificity.</p> Conclusion <p>Given its high sensitivity and specificity for the simultaneous serological identification of <i>M. hominis</i>, <i>U. parvum</i>, and <i>U. urealyticum</i>, MUREAPLEXE may provide a robust and reliable complementary tool for the monitoring of urogenital mycoplasmas.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

MUREAPLEXE: A multiplex recombinant antigen-based ELISA expanding the serological detection spectrum of urogenital mycoplasmas

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月7日

查看全文
  • Sarra Abassi,
  • Safa Boujemaa,
  • Imen Chniba,
  • Sabrina Zidi,
  • Nadine Khadraoui,
  • Behija Mlik,
  • Wassim Y. Almawi,
  • Boutheina Ben Abdelmoumen Mardassi

摘要

Purpose

This study aimed to improve the serological identification of urogenital mycoplasmas through the development of MUREAPLEXE, a recombinant protein-based multiplex ELISA allowing the simultaneous and specific detection of antibodies against Metamycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum.

Methods

Genes encoding the major surface antigens Vaa and P120’ of M. hominis, MBA3 of U. parvum and MBA8 of U. urealyticum were cloned into the prokaryotic expression vector pGEX-4T-1 and expressed in E. coli BL21. Recombinant GST-fusion proteins were purified by affinity chromatography using Glutathione-Sepharose 4B beads and were used to optimize an indirect multiplex ELISA. Both assays were subsequently evaluated using 162 patient sera that had been previously characterized by indirect immunofluorescence (IIF) and Western blot analysis.

Results

Relative to IIF, both ELISA assays demonstrated high sensitivity. All tested sera showed reactivity with their corresponding recombinant antigens. Statistical analyses demonstrated a significant correlation between the two ELISA tests. However, MUREAPLEXE demonstrated markedly higher specificity.

Conclusion

Given its high sensitivity and specificity for the simultaneous serological identification of M. hominis, U. parvum, and U. urealyticum, MUREAPLEXE may provide a robust and reliable complementary tool for the monitoring of urogenital mycoplasmas.